Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi (IST:MEDTR)
Turkey · Delayed Price · Currency is TRY 24.56
-0.12 (-0.49%)
At close: Sep 4, 2026
IST:MEDTR Income Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,575 | 2,874 | 2,741 | 2,097 | 1,596 | 375.93 | |
Revenue Growth | -18.98% | 4.83% | 30.74% | 31.40% | 324.48% | 4.62% |
Cost of Revenue | 1,822 | 2,049 | 1,711 | 1,203 | 936.41 | 216.75 |
Gross Profit | 752.9 | 824.69 | 1,031 | 894.15 | 659.33 | 159.18 |
Selling, General & Admin | 665.8 | 677.45 | 615.03 | 416.51 | 241.54 | 66.76 |
Research & Development | 26.18 | 29.28 | 30.29 | 20.07 | 6.54 | 2.45 |
Other Operating Expenses | 5.27 | 11.72 | 81.12 | 79.02 | 25.38 | 0.88 |
Operating Expenses | 697.24 | 718.44 | 726.44 | 515.6 | 273.46 | 70.09 |
Operating Income | 55.65 | 106.24 | 304.34 | 378.55 | 385.87 | 89.09 |
Interest Expense | -31.92 | -47.36 | -96.55 | -76.1 | -39.68 | -13.37 |
Interest & Investment Income | 183.97 | 189.97 | 83.87 | 220.51 | 48.87 | 19.44 |
Earnings From Equity Investments | -2.84 | -21.58 | -16.16 | -10.49 | -1.97 | -0.5 |
Currency Exchange Gain (Loss) | 18.64 | 62.4 | 133.71 | 162.13 | 190.45 | 107.6 |
Other Non Operating Income (Expenses) | -285.22 | -305.77 | -311.24 | -594.35 | -387.57 | -0.16 |
EBT Excluding Unusual Items | -61.72 | -16.1 | 97.96 | 80.26 | 195.96 | 202.1 |
Gain (Loss) on Sale of Investments | -0.19 | - | -2.93 | - | - | - |
Pretax Income | -61.91 | -16.1 | 95.03 | 80.26 | 195.96 | 202.1 |
Income Tax Expense | -101.5 | -4.36 | 2.98 | 42.85 | 81.66 | 34.4 |
Earnings From Continuing Operations | 39.59 | -11.73 | 92.05 | 37.41 | 114.3 | 167.7 |
Minority Interest in Earnings | -3.19 | 2.46 | 4.06 | -0.06 | 0.03 | - |
Net Income | 36.4 | -9.27 | 96.11 | 37.35 | 114.34 | 167.7 |
Net Income to Common | 36.4 | -9.27 | 96.11 | 37.35 | 114.34 | 167.7 |
Net Income Growth | - | - | 157.37% | -67.34% | -31.82% | 177.53% |
Shares Outstanding (Basic) | 119 | 119 | 119 | 119 | 119 | 119 |
Shares Outstanding (Diluted) | 119 | 119 | 119 | 119 | 119 | 119 |
Shares Change | - | - | - | - | - | 25.93% |
EPS (Basic) | 0.31 | -0.08 | 0.81 | 0.31 | 0.96 | 1.41 |
EPS (Diluted) | 0.30 | -0.08 | 0.81 | 0.31 | 0.96 | 1.41 |
EPS Growth | - | - | 160.54% | -67.71% | -31.85% | 120.30% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 330.65 | 250.79 | 534.54 | 501.56 | -43.66 | 27.72 |
Free Cash Flow Per Share | 2.78 | 2.11 | 4.49 | 4.21 | -0.37 | 0.23 |
Dividend Per Share | - | - | 0.252 | 0.294 | - | - |
Dividend Growth | - | - | -14.29% | - | - | - |
Gross Margin | 29.24% | 28.70% | 37.60% | 42.64% | 41.32% | 42.34% |
Operating Margin | 2.16% | 3.70% | 11.10% | 18.05% | 24.18% | 23.70% |
Profit Margin | 1.41% | -0.32% | 3.51% | 1.78% | 7.17% | 44.61% |
Free Cash Flow Margin | 12.84% | 8.73% | 19.50% | 23.92% | -2.74% | 7.38% |
EBITDA | 224.32 | 273.3 | 418.22 | 448.77 | 431.95 | 100.13 |
EBITDA Margin | 8.71% | 9.51% | 15.26% | 21.40% | 27.07% | 26.63% |
D&A For EBITDA | 168.67 | 167.06 | 113.89 | 70.22 | 46.08 | 11.04 |
EBIT | 55.65 | 106.24 | 304.34 | 378.55 | 385.87 | 89.09 |
EBIT Margin | 2.16% | 3.70% | 11.10% | 18.05% | 24.18% | 23.70% |
Effective Tax Rate | - | - | 3.14% | 53.39% | 41.67% | 17.02% |